B
Bull
Bull · 25%PHGE
$0.42
Scenario price
$1.850
+0.263 (+14.20%)At close
Loading chart…
- High
- 2.158
- Open
- 1.660
- VWAP
- 1.89
- Volume
- 3.40M
- Mkt Cap
- 23.61M
- Low
- 1.650
- Amount
- 6.41M
- EV/EBITDA, TTM
- 0.00
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.
AI analysis of BiomX Inc (PHGE)
HoldBiomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
Valuation Metrics
The current forward P/E ratio for BiomX Inc (PHGE) is 0.00, compared to its 5-year average forward P/E of -0.87.
Alphio AI Price Scenarios for PHGE
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
3.509-04NewsfilterBiomX to Rebrand as Tessera, Launches No-Code AI Command Platform
- 8.509-01Newsfilter
BiomX to Rebrand as Tessera Defense and Homeland Security Inc.
- 7.508-14Newsfilter
BiomX Subsidiary Secures $300,000 Defense Order
8.508-05seekingalphaBiomX Acquires 10% Stake in Motomea to Enhance Drone Testing Capabilities
8.507-28GlobenewswireBiomX Amends Terms of Zorronet Acquisition
PHGE FAQ — answered by Alphio AI
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
Community
More ↗No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.